Qilu Hospital of Shandong University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
Efficacy and Safety of Ruxolitinib in Patients With Myelofibrosis
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 130
- Registration Number
- NCT05410470
Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-05-26
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 430
- Registration Number
- NCT05392712
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma
- Conditions
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 300
- Registration Number
- NCT05327907
- Locations
- 🇨🇳
Department of Gastroenterology,Qilu Hospital,Shandong University, Jinan, Shandong, China
Colonic Glucose vs. Saline Infusion
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 15
- Registration Number
- NCT05302206
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 508
- Registration Number
- NCT05302661
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
mNGS -Guided Antimicrobial Treatment in Early Severe Community-Acquired Pneumonia Among Immunocompromised Patients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 342
- Registration Number
- NCT05290454
- Locations
- 🇨🇳
Qilu Hospital of Shandong university, Jinan, Shandong, China
Extended Resection for Rectal Cancer With Neoadjuvant Radiotherapy
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 40
- Registration Number
- NCT05267275
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
The Observation About the Effects of Internal Carotid Artery Stenosis on Fundus Vessels and the Changes of Fundus Vessels After Interventional Therapy
- Conditions
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 30
- Registration Number
- NCT05260229
- Locations
- 🇨🇳
Department of ophthalmology and neurology at Qilu Hospital of Shandong University, Jinan, Shandong, China
Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-02-17
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 46
- Registration Number
- NCT05243355
- Locations
- 🇨🇳
Shandong Cancer Hospital, Jinan, China
🇨🇳Qilu hospital of Shandong univertisy, Jinan, Shandong, China
Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 106
- Registration Number
- NCT05198856
© Copyright 2024. All Rights Reserved by MedPath